Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Covid-detection dogs study receives funding boost
Bio-detection dogs can sniff-out COVID-19 in people with up to 94 per cent accuracy.
Dogs could play a vital role in preventing the future spread of the pandemic.

UK charity Medical Detection Dogs has received a share of $1 million (£722,000) from the Royal Canin Foundation towards training dogs to detect COVID-19 in humans.

The organisation is working in partnership with the London School of Hygiene and Tropical Medicine and Durham University on the project, which could play a vital role in preventing the further spread of the pandemic in future.

“The nomination for Medical Detection Dogs, COVID Research was submitted by Royal Canin Associates, and every Associate is given the opportunity to vote for those that they believe should be supported by the Foundation,” explained Suzy Roffey, professional national sales manager at Royal Canin. “We were ecstatic that the nomination won the vote and extremely proud of the ongoing work we do in partnership with the organisation.”

Medical Detection Dogs announced earlier this year that bio-detection dogs can quickly and non-invasively sniff out COVID-19 in people with up to 94 per cent accuracy -
even if they are not showing any symptoms. The team hopes that, once fully trained, the dogs could be deployed at airports, concert venues and sports stadiums to supplement ongoing testing. 

Dr Claire Guest, chief scientific officer at Medical Detection Dogs, said: “Knowing that we can harness the amazing power of a dog’s nose to detect COVID-19 quickly and non-invasively gives us hope for a return to a more normal way of life through safer travel and access to public places so that we can again socialise with family and friends.” 

Founded in December 2020, The Royal Canin Foundation provides financial and organisational support to projects across the globe. Its three areas of focus are: the health and welfare of working dogs, pets in support of medical health and pets in support of human mental health.

Medical Detection Dogs research is one of five projects that will receive a share of the US $1 million funds.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.